The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nectin-4 and Trop-2 expression as potential therapeutic target in collecting duct carcinoma: Preliminary results from the CICERONE trial (NCT05372302).
 
Giuseppe Procopio
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; Roche
Research Funding - Gilead Sciences; Ipsen; Janssen; MSD
 
Alessandro Rametta
No Relationships to Disclose
 
Marco Stellato
No Relationships to Disclose
 
Filippo Guglielmo Maria de Braud
No Relationships to Disclose
 
Katia Todoerti
No Relationships to Disclose
 
Luca Agnelli
No Relationships to Disclose
 
Veronica Huber
No Relationships to Disclose
 
Licia Rivoltini
No Relationships to Disclose
 
Luisa Rollo
No Relationships to Disclose
 
Chiara Vela
No Relationships to Disclose
 
Melanie Claps
Travel, Accommodations, Expenses - Bayer; Janssen Oncology
 
Valentina Guadalupi
No Relationships to Disclose
 
Eleonora Gusmaroli
No Relationships to Disclose
 
Simone Rota
No Relationships to Disclose
 
Anna Caliò
No Relationships to Disclose
 
Guido Martignoni
No Relationships to Disclose
 
Elena Verzoni
Consulting or Advisory Role - Janssen Oncology; MSD/AstraZeneca; Pfizer
Speakers' Bureau - AstraZeneca/Merck; Eisai Europe; Ipsen; Janssen Oncology; MSD Oncology; Novartis
 
Matteo Brunelli
No Relationships to Disclose